Bengaluru, India

Venugopalarao Chinimilli


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Venugopalarao Chinimilli: Innovator in Pharmaceutical Sciences

Introduction

Venugopalarao Chinimilli is a prominent inventor based in Bengaluru, India, contributing significantly to the field of pharmaceutical innovations. With a strong focus on improving drug formulations, he holds a total of two patents that reflect his commitment to advancing medical science.

Latest Patents

Chinimilli's latest patents include the development of a novel polymorphic form of nilotinib dihydrochloride hydrate, known as Form X. This invention not only details the unique characteristics of the polymorph but also outlines processes for its preparation and its applications in medicine. Additionally, he has developed a patent for a process to prepare atazanavir sulfate. This process involves contacting atazanavir base with sulfuric acid in a specific solvent combination, leading to the isolation of a substantially pure Compound (A), free from mesityl oxide impurity.

Career Highlights

Venugopalarao Chinimilli is currently associated with Cipla Limited, a well-respected pharmaceutical company known for its contributions to healthcare. His work focuses on enhancing drug efficacy and improving patient outcomes through innovative formulations.

Collaborations

Throughout his career, Chinimilli has collaborated with esteemed colleagues, including Srinivas Laxminarayan Pathi and Dharmaraj Ramachandra Rao. Their teamwork has been instrumental in bringing new pharmaceutical innovations to fruition.

Conclusion

With his expertise and innovative spirit, Venugopalarao Chinimilli continues to push the boundaries of pharmaceutical science. His patents not only pave the way for future developments in medicine but also underline the critical role of inventors in improving health care for communities around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…